Table 1.
Characteristics |
n (Total n=70) |
|
---|---|---|
HCC (n=33) | ICC (n=37) | |
Age (median/range) |
66 (38–76) |
59 (41–79) |
Gender (f/m) |
8/25 |
22/15 |
Primary tumour: |
|
|
Primary/recurrent |
8/25 |
19/18 |
Grading (G1/G2/G3/n.a.) |
1/11/20/12 |
3/17/7/10 |
Child-Pugh class A/B/C/n.a. |
25/3/1/4 |
-- |
Stage IVb |
10 |
21 |
Pretreatment: |
|
|
Hepatic resection |
18 |
12 |
Liver transplantation |
5 |
0 |
Sorafenib/Chemotherapy |
1 |
6 |
Chemoembolisation |
12 |
1 |
Local ablation (RFA, brachytherapy) |
2 |
2 |
Elevated AFP/Ca 19-9 | 24 | 32 |